Is Ozempic approved for weight loss?

No. Ozempic is FDA-approved for type 2 diabetes and cardiovascular risk reduction. The weight-approved version of semaglutide is Wegovy, so using Ozempic for weight is off-label.

Can women take Ozempic for PCOS?

Ozempic is not FDA-approved for PCOS. Any such use is off-label. The 2023 International PCOS Guideline lists anti-obesity medications as an adjunct where weight management is a treatment goal.

Do I need to stop Ozempic before pregnancy?

The FDA label advises stopping semaglutide at least 2 months before a planned pregnancy due to its long half-life. Confirm timing with your clinician; this is a label instruction, not personal advice.

GLP-1 receptor agonist (semaglutide)

Ozempic (Semaglutide) for Women: What to Know

Medically reviewed by Editorial Medical Review, MD, NAMS-CMP · Updated July 2026

Quick answer

Ozempic is semaglutide branded for type 2 diabetes, given as a once-weekly injection. It is FDA-approved to lower blood sugar and reduce cardiovascular risk in type 2 diabetes, not for weight loss, so weight-management use is off-label. Wegovy is the same molecule approved for weight. The label advises stopping before pregnancy.

How it works

Semaglutide mimics GLP-1 to improve insulin release, lower blood sugar, and reduce appetite. In SUSTAIN-6, semaglutide reduced major cardiovascular events in adults with type 2 diabetes. Ozempic approved doses (up to 2 mg weekly) are lower than the 2.4 mg used in Wegovy.

FDA status for weight: Not FDA-approved for weight loss. Ozempic is approved for type 2 diabetes and cardiovascular risk reduction, so any weight-management use is off-label.

Women-specific considerations

These are factual notes from FDA labels and published guidelines, not personal medical advice. Discuss your situation with a licensed clinician.

Off-label for weight

Because Ozempic is not approved for weight, insurers rarely cover it for that purpose. The weight-approved version of the same molecule is Wegovy.

Pregnancy

The label advises discontinuing semaglutide at least 2 months before a planned pregnancy because of its long half-life. It is not recommended during pregnancy.

Breastfeeding

There is no human data on semaglutide in breast milk, and the label does not recommend use while breastfeeding.

Birth control

The semaglutide label does not carry the oral-contraceptive warning that tirzepatide does. Weight loss can still restore ovulation, so reliable contraception matters if pregnancy is not intended.

PCOS

Ozempic is not FDA-approved for PCOS. Any PCOS use is off-label; the 2023 International PCOS Guideline treats anti-obesity medications as an adjunct where weight management is a goal.

Who it is for (eligibility)

The FDA label indicates Ozempic for adults with type 2 diabetes (and, in eligible patients, to reduce cardiovascular risk). Weight-management use is off-label and is a decision made with a licensed clinician.

Cost (cited)

Retail list price

~$935/mo

GoodRx — Ozempic price guide ↗

With commercial insurance (diabetes)

$25-$100/mo copay

GoodRx — Ozempic price guide ↗

See the full cost breakdown in our cost guide.

Providers we review that offer this

Editorial reviews only — not treatment recommendations. Prescribing decisions rest with a licensed clinician. For the full directory, see all GLP-1 for women providers.

Form Health — Board-certified obesity medicine physicians prescribing GLP-1s. Often insurance-covered — among the most affordable options when insurance applies.
Noom Med — Noom’s GLP-1 telehealth arm pairing semaglutide/tirzepatide prescribing with behavior-change coaching.
Plushcare GLP-1 — Primary care telehealth that prescribes Wegovy and Zepbound when clinically appropriate. Insurance-friendly.

Frequently asked questions

Is Ozempic approved for weight loss?: No. Ozempic is FDA-approved for type 2 diabetes and cardiovascular risk reduction. The weight-approved version of semaglutide is Wegovy, so using Ozempic for weight is off-label.
Can women take Ozempic for PCOS?: Ozempic is not FDA-approved for PCOS. Any such use is off-label. The 2023 International PCOS Guideline lists anti-obesity medications as an adjunct where weight management is a treatment goal.
Do I need to stop Ozempic before pregnancy?: The FDA label advises stopping semaglutide at least 2 months before a planned pregnancy due to its long half-life. Confirm timing with your clinician; this is a label instruction, not personal advice.

Sources

Every claim above resolves to an FDA label, published trial, guideline, or manufacturer / GoodRx pricing page. External links open in a new tab.

For the general (non women-specific) mechanism, dosing, and side-effect incidence, see our semaglutide medication overview.

Compare other options

Wegovy for women — GLP-1 receptor agonist (semaglutide 2.4 mg)
Zepbound for women — GIP/GLP-1 receptor dual agonist (tirzepatide)
Oral semaglutide (Rybelsus) for women — Oral GLP-1 receptor agonist (semaglutide tablet)
Back to the GLP-1 for women guide

ClearHormones updates this explainer as FDA status and pricing change. Verify current approval status and pricing on the manufacturer or FDA page before acting.